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Trichiasis Surgery in The Gambia: A 4-Year
Prospective Study
Saul N. Rajak,1 Pateh Makalo,2 Ansumana Sillah,3 Martin J. Holland,1,2
David C. W. Mabey,1 Robin L. Bailey,1 and Matthew J. Burton1
PURPOSE. Trachoma is the leading infectious cause of blindness.
Conjunctival Chlamydia trachomatis infection causes scar-
ring, entropion, trichiasis, and blinding corneal opacification.
Worldwide, there are 8 million people with trichiasis. Al-
though trichiasis surgery can reduce the risk of blindness,
retrospective data suggest that long-term recurrence rates may
be high. A 4-year prospective investigation of recurrent trichi-
asis was conducted in The Gambia.
METHODS. Patients with trichiasis were examined at baseline, 6
months, 1 year, and 4 years after posterior lamellar tarsal
rotation surgery. Conjunctival swabs for bacteriology and PCR
for C. trachomatis were collected at baseline, 6 months, and 1
year.
RESULTS. Three hundred fifty-six Gambian patients were en-
rolled at baseline and 266 were reassessed at 4 years (94% of
surviving patients). The recurrence rates were 32%, 40%, and
41% at 6 months, 1 year, and 4 years, respectively. At 4 years,
30% of patients had bilateral trichiasis and 21% had bilateral
corneal opacity. Recurrence was associated with severe con-
junctival inflammation and severe trichiasis (10 lashes) at
baseline.
CONCLUSIONS. Trichiasis recurrence rates were high, and most
cases recurred within 6 months of surgery. The results suggest
that there are important aspects of surgical technique and
quality that should to be addressed. Persistent inflammation is
strongly associated with recurrence at 4 years. (Invest Oph-
thalmol Vis Sci. 2010;51:4996–5001) DOI:10.1167/iovs.10-
5169
Trachoma is the leading infectious cause of blindnessworldwide. Repeated conjunctival infection by Chla-
mydia trachomatis provokes a chronic inflammatory pro-
cess that leads to scarring, cicatricial entropion, and trichi-
asis. Direct eyelash trauma, secondary bacterial infection,
and a dry ocular surface may cause blinding corneal opaci-
fication (CO).1–7 The World Health Organization (WHO)
estimates that there are currently 40 million people with
active trachoma and 8.2 million people with trachomatous
trichiasis (TT) that has not been treated surgically.8 The
Gambia is a small country (population, 1.5 million) and the
prevalences of TT and trachoma have decreased markedly in
recent years. However, recent estimates suggest that more
than 10,000 people still have TT.8 National prevention of
blindness programs in trachoma-endemic countries are seek-
ing to control the disease through the implementation of the
SAFE Strategy: Surgery for trichiasis, Antibiotic distribution,
Facial cleanliness, and Environmental improvements to re-
duce transmission.9
Trichiasis is the main risk factor for corneal opacification
and should be treated. Successful surgery is likely to halt the
progression of corneal opacity. Conversely, postsurgical re-
currence confers a significantly increased risk of progressive
corneal opacity.1 In addition, alleviation of trichiasis reduces
photophobia and epiphora and allows the corneal scar to
fade in some patients.1,10 Accordingly, visual acuity was
shown to improve significantly (0.12 logMAR units; P 
0.001; odds ratio [OR], 1.68; 95% confidence interval [95%
CI], 1.04–2.70) 6 months after surgery in one study and by
0.14 units at 12 months in another (P  0.001).10,11
A wide variety of treatments are used for TT. Nonsurgical
options include cryotherapy or thermal ablation of lash follicles
by electroepilation or laser photocoagulation. Numerous sur-
gical procedures have been described, and several of these are
in routine use in trachoma control programs in endemic coun-
tries, including the bilamellar tarsal rotation (BLTR), the Trabut
procedure, and other variants of posterior lamellar tarsal rota-
tion (PLTR).12
Recurrent trichiasis, developing months to years after
surgery, is a frequent problem. Recurrence rates have been
reported to range from 7% at 1 year to 62% at 3 years.1,13–19
There are two distinct forms of recurrence: early “surgical
failure” and late “disease progression.” Early recurrence may
be related to the operation type, the surgeon’s technical
ability, or the choice of needles or sutures.10,14,16,17 Factors
associated with later recurrence include infection (Chla-
mydia or other bacteria), older age, severe conjunctival
inflammation, and preoperative disease severity.1,10,13,16,17
Much of the data on recurrence are not from prospective
cohorts, but rather from retrospective tracing of cases in
surgical records. In 2001 to 2002, we recruited people with
TT into a randomized controlled trial of postoperative
azithromycin after trichiasis surgery. This cohort of patients
offers an opportunity to prospectively examine long-term
outcome after trichiasis surgery. The 6- and 12-month out-
comes were reported.10
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METHODS
Ethical Approval
The study was approved by the Gambian Government/Medical Re-
search Council Joint Ethics Committee (SCC Number 858). Informed
consent for the study was obtained at enrollment. The research ad-
hered to the tenets of the Declaration of Helsinki.
Study Participants
The detailed methodology has been published.10 Briefly, subjects who
had not had surgery for trichiasis were identified from the Gambian
National Eye Care Programme (NECP) database, community ophthal-
mic nursing records, and village screening. Subjects were recruited at
surgical campaigns. All subjects who attended a surgical campaign and
had trichiasis were offered TT surgery. There was no bias toward
offering surgery to more severe TT cases, although presentation bias is
possible, as more severe cases are more likely to present. Individuals
who had undergone surgery for trichiasis were not recruited into the
study at baseline, and pregnant women (self-reported) were excluded.
Clinical Assessment
Patients were assessed at baseline, 6 months, 1 year, and 4 years. Study
subjects were examined with 2.5 loupes and a flashlight, according
to the detailed WHO trachoma-grading system (FPC).20 One ophthal-
mologist performed the baseline and 1-year examinations and a second
performed the 4-year examinations. The 6-month examination was
performed by a community ophthalmic nurse. The baseline examina-
tion was performed at the surgical campaign. All subsequent examina-
tions were conducted in the patient’s village. The death of a participant
was ascertained by information from a close relative. Examinations
were standardized to those conducted by the first ophthalmologist
through a joint examination exercise at the beginning of the 4-year
follow-up. The level of agreement between the two observers who
conducted the 1- and 4-year examinations for the presence of trichiasis
(binary outcome) was   1.00 and 0.87 and 0.77 for corneal opacity
and papillary inflammation, respectively.20 Visual acuity was measured
by using a reduced logMAR tumbling-E chart on all three occasions,
except 6 months.21 Conjunctival swabs for bacteriology and C. tracho-
matis PCR were collected at baseline, 6 months, and 1 year. In the light
of the high recurrence rates at 1 year, we added the additional 4-year
follow-up, which was not prespecified in the original study plan, to
assess whether recurrence continued.10
Treatment
TT was corrected surgically with the PLTR technique. In patients with
bilateral trichiasis, one eye was randomly selected as the study eye, but
both eyes were surgically treated. All surgery was performed by trained
community ophthalmic nurses. The patients were randomized to ei-
ther the azithromycin treatment or control arms of the trial. Treatment
allocations were concealed in opaque sequentially numbered enve-
lopes. Separate randomization sequences were generated for each
surgeon from random number tables and blocked in groups of four.
Those in the azithromycin arm received a single oral dose after surgery
and at 6 months. All patients were given tetracycline eye ointment to
take twice daily for 2 weeks after surgery, according to Gambian
National Eye Care Program guidelines. Recurrent trichiasis was man-
aged according to Gambian guidelines: epilation for a few peripheral
lashes or referral for repeat surgery for multiple/central lashes.
Data Analysis
The primary outcome was recurrent trichiasis, defined as one or more
lashes touching any part of the globe in primary position. Secondary
outcomes were visual acuity and corneal opacification. For visual
acuities of counting fingers or less, logMAR values were applied:
counting fingers, 2.0; hand movements, 2.5; and perception of light,
3.0. The Wilcoxon signed rank test was used to compare the medians
of the number of trichiatic lashes, as this variable has a skewed
distribution (Stata 9; Stata Corp., College Station, TX).
RESULTS
Study Subjects
At baseline, 356 Gambians with TT were recruited. Four years
after surgery, 266 (75%) were re-examined, 68 (19%) had died,
and 22 (6%) were untraceable. Overall, 94% of the surviving
patients were seen. The median age at baseline of those re-
examined, expired, and untraceable at 4 years was 60 (inter-
quartile range [IQR], 47–70), 70 (IQR, 60–76), and 48 (IQR,
35–60) years, respectively. Of those seen at 4 years, 203 (76%)
were women. Demographic and clinical characteristics are
shown in Table 1.
Recurrent Trichiasis
Trichiasis was present in 110 (41%) of 266 study eyes 4 years
after surgery. This result compares with 32% at 6 months and
40% at 1 year.10 Lashes were touching the cornea in 101 (92%)
of 110 of these eyes, and only the medial and/or lateral con-
junctiva in the remaining 9. At 4 years, the median number of
lashes touching the eye (lash burden) in patients with recur-
rent TT was two (total range, 0 [epilating] to 56; IQR, 1–8).
This count was significantly less than the lash burden at base-
line in the same eyes (median 8; total range, 0[epilating] to 74;
IQR, 5–19; Wilcoxon matched-pairs signed rank test: z  5.87,
P  0.001).
A comparison of trichiasis status at years 1 and 4 is shown
in Table 2. Trichiasis status was unchanged in 224 (84%) study
eyes; 140 had no TT and 84 had TT at both time points.
Between year 1 and year 4, 26 (10%) eyes developed recurrent
TT, and TT resolved in 16 (6%) eyes. Five of these 16 eyes had
undergone reoperation. The proportion of people successfully
epilating (i.e., trichiasis controlled by epilation) increased from
10% at baseline to 25% at year 4. Bilateral TT was present in 80
(30%) of 266 people. The TT recurrence rate at year 1 among
those who were not traced or had died by year 4 was 48%,
compared with 37% at year 1 in those who were seen at 4
years.
Univariate associations and multivariate logistic regression
models between potential risk factors and any recurrent TT
and major TT (greater than five trichiatic lashes) are shown in
Table 3. Severe TT (10 lashes) at baseline was strongly asso-
ciated with major TT at 4 years. Recurrent TT at 4 years was
associated with increasing conjunctival inflammation at 4
years. The association was stronger for major TT than for any
TT. There was a nonsignificant association between the pres-
ence of trichiasis at 4 years and being male. No significant
associations were found between recurrent TT and age, C
trachomatis infection status at 1 year, ethnicity, literacy, or
education.
Univariate associations for developing incident recurrent
TT between years 1 and 4 are presented in Table 4. In multi-
variate logistic regression models, none of these associations
were significant.
Corneal Opacification
At 4 years, 98 (36%) study eyes had visually significant CO
(CC2/CC3 or phthisis). Among the people who were seen at
the 1-year but not the 4-year follow-up, the proportion with CO
was similar (26/65; 40%). Bilateral visually significant CO was
found in 56 (21%) people at 4 years. When compared with that
at the 1 year time point, the corneal scar grade at 4 years
remained unchanged in 195 (73%) study eyes, deteriorated in
58 (22%), and improved in 13 (5%). Thirty-one patients devel-
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oped pupil-obscuring opacity between baseline and the 4 year
follow-up. Fifteen (48%) of these patients had recurrent TT at
4 years. Univariate and multivariate associations with visually
significant CO are shown in Table 5. The incidence of new
corneal opacity at 4 years (when compared to baseline) was
too small to test for associations.
Visual Acuity
The comparative visual acuity levels between baseline and 1
year and baseline and 4 years are shown in Table 6. Between
baseline and 1 year after surgery, visual acuity improved in 40%
of the patients. By 4 years, there was a sustained improvement
in 18% when compared with baseline. It is unknown how
many patients received cataract surgery or refractive correc-
tion during the follow-up period, but it is likely to be few if any,
as the threshold for surgery is relatively high, and spectacles
are not widely available in rural areas. Poor vision (logMAR 
0.7) is strongly associated with the presence of significant
corneal opacity (OR, 10.1; 95% CI, 5.1–20.4; P 0.001). There
was a nonsignificant trend toward improving vision in those
who did not have recurrent trichiasis (OR, 1.90; 95% CI, 0.96–
3.75; P  0.065).
DISCUSSION
Recurrent trichiasis after surgery is a major problem in the
prevention of blindness from trachoma. Although in tightly
supervised clinical trials recurrence rates as low as 7% at 1 year
TABLE 1. The Demographic and Clinical Characteristics of Subjects at Each Time Point
Baseline
(n  356)
1 Year
(n  332)
4 Years
(n  266)
Demographics
Sex, female 253 (71) 241 (73) 203 (76)
Median age, y (IQR)* 60 (50–70) 61 (51–71) 64 (51–74)
Visual acuity (logMAR)
0–0.3 23 (9) 46 (14) 45 (17)
0.4–0.7 86 (25) 84 (25) 61 (23)
0.8–2.0 158 (46) 117 (35) 24 (9)
Mean VA (95% CI)† 0.81 (0.20–1.60) 0.66 (0.10–1.47) 0.51 (0.10–1.10)
Count fingers 18 (5) 23 (7) 27 (10)
Hand movements 25 (7) 23 (7) 71 (27)
Perception of light 13 (4) 23 (7) 25 (9)
No perception of light 23 (7) 13 (4) 12 (5)
Measurement not possible 10 (3) 3 (1) 1 (0)
Corneal opacity
CC 0 181 (51) 157 (47) 97 (36)
CC 1 71 (20) 67 (20) 72 (27)
CC 2 46 (13) 68 (21) 68 (25)
CC 3 57 (16) 36 (11) 28 (10)
Phthisis 1 (0) 3 (1) 2 (1)
Trichiasis
Any trichiasis (including epilators) 356 (100) 131 (40) 110 (41)
Any lashes touching cornea 350 (98) 106 (32) 74 (28)
Mean lashes, n 12.6 4.5 3.0
Median of lashes, n (in patients with TT) 8 5 2
Number of lashes touching eye
0 35 (10)‡ 263 (62) 182 (68)
1–4 39 (11) 79 (18) 43 (16)
5–9 128 (36) 45 (11) 19 (7)
10–19 81 (23) 20 (5) 11 (4)
20 73 (21) 19 (5) 11 (4)
Conjunctival inflammation
P0 55 (15) 107 (32) 66 (25)
P1 87 (24) 91 (27) 117 (44)
P2 120 (34) 75 (23) 58 (22)
P3 94 (26) 47 (14) 24 (9)
Not everted/examined 0 (0) 11 (3) 2 (1)
Infection
C. trachomatis present 6 (2) 3 (1) — —
Pathogenic bacteria present 108 (31) 50 (16) — —
Data are expressed as the number of subjects (%), unless stated otherwise.
* Median age at the time of follow-up of patients examined.
† Arithmetic mean of visual acuities where vision sufficiently good to test with a logMAR chart.
‡ Trichiatic lashes epilated.
TABLE 2. Comparison of Trichiasis Status in the Study Eyes at the
1- and 4-Year Follow-ups
TT at 4 Years
TT at 1 Year Yes No Total
Yes 84 (31.7) 16 (6) 99
No 26 (9.8) 140 (52.8) 166
Total 110 155 265*
Data are the number of eyes (% of total).
* One individual seen only at 4 years.
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have been reported, it is likely that rates are much higher
under operational conditions.13,18 In our study, the recurrence
rate at 4 years was 41%. Most recurrences occurred within the
first year (32% at 6 months, 40% at 12 months).10 However, an
additional 26 cases of recurrence were recorded between 1
and 4 years after surgery. The uncensored recurrence rate at 4
years (including those who had died or were lost to follow-up)
is likely to have been higher than 41%, as the recurrence rate
at 12 months in these individuals was 48%, compared with 37%
in those who were also seen at 4 years. Despite these high
recurrence rates, the lash burden in those eyes with trichiasis
was much less than at baseline. The risk of CO increases with
increasing lash burden.10,17 Therefore, even partially success-
ful surgery is likely to be beneficial.
Early recurrence is probably related to surgical factors,
whereas late recurrence may reflect an ongoing cicatrizing
process. In our study, 75% of recurrent TT had developed by 6
months, and there was significant intersurgeon variation.10
Therefore, in this low-prevalence setting, there were probably
important issues relating to surgical technique and quality that
should be addressed. No long-term prospective studies of post-
surgical recurrence have been reported from high-prevalence
settings, where late recurrence driven by ongoing C. tracho-
matis infection may be more frequent.
BLTR and PLTR are the most commonly used procedures to
treat TT in trachoma-endemic settings. PLTR is used in The
Gambia. The WHO recommends BLTR, although the only small
comparative trial of the two procedures found similar out-
comes.22,23 A larger trial with longer follow-up is needed, to
conclusively determine whether these two procedures are
comparable. Variations in surgical technique are likely to influ-
ence the success of the operation: incision length, degree of
eversion, suture material, and tension.18,24 As with other sur-
gical procedures, it is likely that performing the surgery more
frequently leads to improved quality and may in part explain
the significant intersurgeon variation in outcomes reported at 1
year, although all surgeons receive the same National Eye Care
Programme training.10 In light of that study, all Gambian trichi-
asis surgeons underwent refresher training and recertification.
High early recurrence rates may result from the lid’s reverting
to the entropic position soon after the removal of the silk
sutures, removed at 7 to 10 days per WHO guidelines.22 Stable
wound healing in heavily scarred tissue may not have occurred
by this time. A recent report suggested that better results are
attained with the use of absorbable sutures, perhaps because
they hold the lid in position for a longer period. However,
differences in socioeconomic status between groups receiving
different suture materials may have confounded this finding.14
TABLE 4. Univariate Associations of Various Factors and New Recurrence between 1 Year and 4 Years
after Surgery
New TT at 4 Years*
Variable OR 95% CI P
Sex, male 2.76 1.13–6.78 0.026
Age 60 0.76 0.30–1.94 0.57
Severe TT (10 lashes) at baseline 0.89 0.38–2.11 0.80
Bacterial infection at baseline 0.93 0.34–2.51 0.89
Bacterial infection at 1 year 0.60 0.13–2.79 0.52
Conjunctival inflammation at 4 years† 2.35 0.94–5.90 0.068
* Cases of recurrent TT at 1 year were excluded; 166 individuals were included in the analysis, of
which 26 had incident trichiasis.
† Binary outcome for conjunctival inflammation (P0/P1 vs. P2/P3).
TABLE 3. Univariate Associations and Multivariate Logistic Regression Models for Various Factors and any TT and Major TT at 4 Years
after Surgery
Any TT at 4 Years Major TT at 4 Years
Variable OR 95% CI P OR 95% CI P
Univariate analysis
Sex, male 1.96 1.11–3.47 0.021 0.93 0.40–2.16 0.87
Age 60 years at baseline 1.41 0.85–2.35 0.18 2.64 1.29–5.38 0.008
Severe TT (10 lashes) at baseline 2.15 1.31–3.54 0.003 13.56 4.04–45.49 0.001
Bacterial infection at baseline 1.15 0.67–1.97 0.62 2.53 1.23–5.20 0.011
Bacterial infection at 1 year 1.86 0.93–3.69 0.078 5.17 2.34–11.45 0.001
Conjunctival inflammation at 4 years*
P1 1.41 0.72–2.77 0.32 6.64 0.84–52.66 0.073
P2 4.00 1.87–8.56 0.001 13.33 1.65–107.73 0.015
P3 10.73 3.47–33.21 0.001 89.6 10.59–758.06 0.001
Multivariate logistic regression model
Sex (male) 1.83 0.98–3.42 0.060 0.51 0.17–1.54 0.23
Severe TT (10 lashes) at baseline 2.16 1.26–3.71 0.005 14.04 3.90–50.55 0.001
Conjunctival inflammation at 4 years*
P1 1.40 0.70–2.78 0.34 7.56 0.93–61.34 0.058
P2 4.08 1.87–8.88 0.001 16.67 1.99–139.67 0.009
P3 8.77 2.76–27.81 0.001 108.95 11.61–1022.13 0.001
Major TT is more than five ingrowing lashes.
* Relative to P0.
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The association between severe disease and recurrence has
been reported.10,17,18,25–30 The patients in our study tended to
have slightly more severe trichiasis than those in other trials,
and that difference may have contributed to the less favorable
outcome. More severe disease makes the surgery harder, espe-
cially when the lids are shortened, more scarred, and inflamed.
Similarly, repeat surgery is technically more challenging, as lids
are often more scarred and distorted by previous surgery.
These cases should be referred to an ophthalmologist or expe-
rienced TT surgeon.
Patients with trichiasis often had persistent tarsal conjunc-
tival inflammation that was strongly associated with the pres-
ence of recurrence, particularly major recurrence at 4 years.
However, the causality in the relationship between inflamma-
tion and recurrence is unclear and may go both ways. We
suggest that, although early recurrence primarily results from
surgical factors, a chronic inflammatory and cicatrizing process
causes the development of recurrence many years later. C.
trachomatis infection is probably the major driver of active
disease in children and perhaps postsurgical recurrence in
high-prevalence areas, although this has never been demon-
strated. However, chlamydial infection was rare and not asso-
ciated with recurrence in these Gambian patients, and its role
remains uncertain in other populations.10,19,26 Pathogenic bac-
teria were strongly associated with recurrence at 1 year in this
cohort of patients, suggesting that they may play a role in
driving the clinically observed inflammation.10 In addition, a
large prospective sample with repeat bacteriology investiga-
tions, and laboratory studies of the inflammatory mediators
would be needed to further investigate this process. Other
factors, for which there is good evidence of an association with
increased recurrence, are a history of previous surgery, older
age, female sex, and immunogenetic factors.1,10,17–19,28,31–33
Recurrent trichiasis has been associated with the use of three
or more sutures in surgery, making postoperative adjustments
to the sutures, living with children who are infected with C.
trachomatis, and eye laterality.1,14,19,24,28
This group of patients had high levels of visually disabling
CO (36%). Many patients had bilateral opacification (21%) and,
given the worsening corneal disease and trichiasis recurrence
observed over 4 years, many of these individuals are at high
risk of blindness. Major TT at baseline is a strong risk factor for
CO at 4 years. A greater lash burden probably has a greater
abrasive effect. However, the large, dense, deep scars that are
seen in patients with TT suggest that secondary microbial
keratitis plays a role. This notion is supported by the strong
association between the presence of a conjunctival bacterial
pathogen at baseline and CO at 4 years. It is likely that eyes
with more trichiatic lashes are more susceptible to damaging
bacterial infections. Prevention and/or prompt treatment of
pathogenic conjunctival and corneal bacterial infection in pa-
tients with TT is likely to be beneficial, although studies to
assess this possibility have not been conducted. Despite the
likely progression of cataract and CO in some patients (22%),
the visual acuity was significantly better in 99 patients at 1 year
and in 47 patients at 4 years when compared with baseline.
There was a nonsignificant trend toward improving vision in
patients without recurrence at 4 years. Successful trichiasis
TABLE 5. Univariate Associations and Multivariate Logistic Regression Model for Various Factors and
Central or Pupil-Obscuring CO (CC2, CC3, or Phthisis) at 4 Years after Surgery
Pupil-Obscuring/Central Corneal Opacity
Variable OR 95% CI P
Univariate analysis
Sex, male 1.17 0.66–2.09 0.59
Age 60 years 2.06 1.23–3.46 0.006
Any TT at 4 years 2.00 1.21–3.33 0.007
New TT recurrence at 4 years 1.69 0.71–4.06 1.69
Major TT (more than 5 lashes) at 4 years 4.27 2.03–9.02 0.001
Severe TT (10 lashes) at baseline 2.09 1.26–3.49 0.004
Bacterial infection at baseline 3.59 2.05–6.28 0.001
Bacterial infection at 1 year 2.80 1.39–5.62 0.004
Conjunctival inflammation at baseline 1.44 1.12–1.86 0.005
Conjunctival inflammation at 1 year 1.31 1.05–1.63 0.016
Conjunctival inflammation at 4 years 1.89 1.41–2.52 0.001
Multivariate logistic regression model
Age 60 years 1.78 1.01–3.12 0.046
Major (more than five lashes) TT at 4 years 3.23 1.47–7.09 0.004
Conjunctival pathogen at baseline 3.33 1.86–5.94 0.001
TABLE 6. Change in Visual Acuity between Baseline and 1 Year and Baseline and 4 Years
Baseline to 4 Years
Visual Acuity* Baseline to 1 Year All Recurrence No Recurrence
Improved, 2 logMAR lines 99 (40) 47 (18) 14 (13) 33 (22)
Same, within 2 logMAR lines 111 (45) 92 (35) 41 (38) 51 (34)
Deteriorated, 2 logMAR lines 35 (14) 121 (47) 54 (50) 67 (44)
Total 241 260 109 151
Data are expressed as the number (%).
* For visual acuities of counting fingers or less, logMAR values were applied: counting fingers, 2.0;
hand movements, 2.5; and perception of light, 3.0.
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treatment probably facilitates visual improvement by allowing
a normal tear film, which reduces photophobia and possibly
enables corneal scars to fade slightly. It is important to treat
patients with TT as soon as possible, and it seems likely that
well-conducted epilation is a sensible interim measure for re-
ducing lash burden until surgery takes place.
High recurrence rates in TT surgery are a major concern.
Patients thought to be successfully treated remain at risk of
recurrence. Individuals are likely to share any negative experi-
ence with other sufferers, discouraging the uptake of surgery.
Both these factors greatly impede the control of blinding tra-
choma. The findings in this long-term, prospective study sug-
gests that, in this environment, most recurrence occurs within
the first few months after surgery and that surgical factors,
such as technique and training, are very important determi-
nants of the outcome. We have observed a strong association
between increasing conjunctival inflammation and recurrent
trichiasis at 4 years, which warrants further investigation.
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